Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 32 clinical trials
Featured trial
Episodic Migraine: Phase 3 Study of BOTOX (Botulinum Toxin Type A) for the Prevention of Migraine in Subjects with Episodic Migraine

The purpose of this study is to see if the study drug, BOTOX®, is safe and helps prevent episodic migraines in adults that experience 6-14 migraine days per month and less than 15 headache days

  • 0 views
  • 21 Apr, 2022
  • 1 location
Featured trial
Migraine

A Study to Investigate the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants with Episodic Migraine

  • 0 views
  • 01 Feb, 2022
  • 1 location
Featured trial
Dreading your next migraine attack?

The CHALLENGE-MIG (name of study) is a clinical research study comparing 2 approved medications for the prevention of episodic migraine

  • 0 views
  • 10 Mar, 2022
  • 1 location
Featured trial
Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine

To evaluate the safety and tolerability of atogepant 30 mg and 60 mg once a day for the prevention of migraine in participants with episodic migraine.  

  • 133 views
  • 22 Feb, 2019
  • 1 location
Featured trial
Migraine

The purpose of this study is to assess whether galcanezumab is superior to rimegepant in the prevention of migraine in participants with episodic migraine. The study duration will be

  • 0 views
  • 18 Apr, 2022
  • 1 location
Featured trial
A Phase 3, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy, Safety, And Tolerability Of Atogepant For The Prevention Of Chronic Migraine (PROGRESS)

This is a 20-week study to evaluate the efficacy, safety, and tolerability of once-daily oral Atogepant for the prevention of migraine in participants with episodic migraine

  • 354 views
  • 03 Aug, 2020
  • 1 location
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

categorized according to the frequency of attacks as episodic migraine (EM) or chronic migraine (CM). This study will assess the effects of BOTOX in preventing migraine in adult participants with EM.

  • 28 views
  • 18 Jun, 2022
  • 76 locations
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (REBUILD-1)

The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine. The primary

  • 214 views
  • 19 Jun, 2022
  • 72 locations
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will assess the safety and efficacy of the combination use of ubrogepant for the acute treatment of migraine headache in participants taking atogepant once daily for preventive …

  • 0 views
  • 14 Jun, 2022
  • 33 locations